Briefing stream
Concise updates for busy readers: what changed, why it matters and which source links deserve a closer read.
Momentum strategies are prevalent in global markets, but institutional investors need to be wary of the risks behind trend chasing. This article deeply analyzes the driving factors, capital flows, and long-term investment logic of momentum trading.
Analyze the impact of ESG Pro becoming an official endorser of SRS on the UK social housing investment landscape, explore how standardized ESG reporting attracts institutional capital into the affordable housing sector, and discuss long-term investment trends.
In June 2026, hedge funds achieved double-digit returns by increasing short selling and betting on healthcare, but suffered losses in crude oil and commodity trading. This article analyzes the market logic and risks behind the divergence of current hedge fund strategies, based on data from Goldman Sachs and Winton Fund.
Measurabl and CRREM jointly released the first climate transition risk dataset targeting global listed real estate companies (FTSE EPRA Nareit Developed Index), covering approximately $1.7 trillion in market capitalization, filling a critical gap for institutional investors in standardized, comparable company-level transition risk analysis.
ESG has evolved from a compliance obligation to a core business strategy. Asian real estate and infrastructure companies that want to win financing and institutional trust must deeply integrate ESG into their business decisions.
ESG disclosure has shifted from a compliance burden to a core differentiator in capital markets. Based on research from MSCI and others, this article analyzes how ESG performance directly impacts financing costs and corporate valuation, and explores the logic behind institutional investors incorporating ESG into their investment decisions.
In an environment of elevated global market valuations, institutional investors are reexamining the long-term role of small-cap value stocks and emerging market value stocks in their allocations. Drawing on Rob Arnott’s views, this article analyzes why capital is gradually shifting from U.S. growth stocks toward cheaper corners of the market, and what that means for asset allocation, risk management, and long-term portfolios.
Against the backdrop of artificial intelligence continuing to attract global capital inflows, some institutional investors have begun to reassess the long-term allocation value of biotechnology, viewing it as a diversification approach to hedge against overcrowding in a single technology narrative. This article analyzes the macro and structural reasons behind this shift from the perspectives of capital flows, valuation conditions, and institutional asset allocation logic.